Search Results - "Harrer, M."

Refine Results
  1. 1

    Psychotherapies for generalized anxiety disorder in adults: systematic review and network meta-analysis of randomized-controlled trials by Papola, D, C Miguel Sanz, Mazzaglia, M, Franco, P, Tedeschi, F, Romero, S A, Patel, A R, Ostuzzi, G, Gastaldon, C, Karyotaki, E, Harrer, M, Purgato, M, Sijbrandij, M, Patel, V, Furukawa, T A, Cuijpers, P, Barbui, C

    Published in European psychiatry (01-08-2024)
    “…IntroductionGeneralized anxiety disorder (GAD) is one of the most common mental disorders in adults. Psychotherapies are among the most recommended treatment…”
    Get full text
    Journal Article
  2. 2

    Patients' experiences in a guided Internet- and App-based stress intervention for college students: A qualitative study by Fleischmann, R.J., Harrer, M., Zarski, A.-C., Baumeister, H., Lehr, D., Ebert, D.D.

    “…Academic education is often associated with increased stress and adverse effects on mental health. Internet-based interventions have shown to be effective in…”
    Get full text
    Journal Article
  3. 3

    Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease by Dejaco, C., Harrer, M., Waldhoer, T., Miehsler, W., Vogelsang, H., Reinisch, W.

    Published in Alimentary pharmacology & therapeutics (01-12-2003)
    “…Summary Background : Antibiotics and thiopurines have been employed in the management of fistulizing Crohn's disease, although evidence of their efficacy is…”
    Get full text
    Journal Article
  4. 4

    The impact of intestinal resection on serum levels of anti-Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn's disease by Eser, A., Papay, P., Primas, C., Pernicka, E., Harrer, M., Dejaco, C., Novacek, G., Lichtenberger, C., Angelberger, S., Kazemi, L., Mikulits, A., Vogelsang, H., Reinisch, W.

    Published in Alimentary pharmacology & therapeutics (01-01-2012)
    “…Aliment Pharmacol Ther 2012; 35: 292–299 Summary Background  Antibodies to Saccharomyces cerevisiae (ASCA) are highly prevalent in sera of patients with…”
    Get full text
    Journal Article
  5. 5

    Interaction of vehicle and steering system regarding on-centre handling by Pfeffer, P. E., Harrer, M., Johnston, D. N.

    Published in Vehicle system dynamics (01-05-2008)
    “…For the on-centre handling behaviour of vehicles the steering system is absolutely important. To investigate the interaction of the vehicle and steering system…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The gender issue: epidemiology of ankle injuries in athletes who participate in basketball by Hosea, T M, Carey, C C, Harrer, M F

    Published in Clinical orthopaedics and related research (01-03-2000)
    “…The increased participation of women in organized athletics has resulted in an interest in gender-related injury patterns. Previous reports have indicated an…”
    Get more information
    Journal Article
  8. 8

    An open‐label trial of the selective cyclo‐oxygenase‐2 inhibitor, rofecoxib, in inflammatory bowel disease‐associated peripheral arthritis and arthralgia by Reinisch, W., Miehsler, W., Dejaco, C., Harrer, M., Waldhoer, T., Lichtenberger, C., Vogelsang, H.

    Published in Alimentary pharmacology & therapeutics (01-06-2003)
    “…Summary Background: Conventional non‐steroidal anti‐inflammatory drugs have been associated with an increased risk of exacerbation of inflammatory bowel…”
    Get full text
    Journal Article
  9. 9

    A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis by Tilg, H, Vogelsang, H, Ludwiczek, O, Lochs, H, Kaser, A, Colombel, J-F, Ulmer, H, Rutgeerts, P, Krüger, S, Cortot, A, D’Haens, G, Harrer, M, Gasche, C, Wrba, F, Kuhn, I, Reinisch, W

    Published in Gut (01-12-2003)
    “…Background: Pilot studies of interferon α (IFN-α) suggest a high remission rate in the treatment of active ulcerative colitis. We evaluated the safety of…”
    Get full text
    Journal Article
  10. 10

    Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice by Kadambi, V J, Ponniah, S, Harrer, J M, Hoit, B D, Dorn, 2nd, G W, Walsh, R A, Kranias, E G

    Published in The Journal of clinical investigation (15-01-1996)
    “…Phospholamban is the regulator of the cardiac sarcoplasmic reticulum (SR) Ca(2+)-ATPase activity and an important modulator of basal contractility in the…”
    Get full text
    Journal Article
  11. 11

    Phospholamban Gene Dosage Effects in the Mammalian Heart by Luo, Wusheng, Wolska, Beata M, Grupp, Ingrid L, Harrer, Judy M, Haghighi, Kobra, Ferguson, Donald G, Slack, Jay P, Grupp, Gunter, Doetschman, Thomas, Solaro, R. John, Kranias, Evangelia G

    Published in Circulation research (01-05-1996)
    “…Phospholamban ablation has been shown to result in significant increases in cardiac contractile parameters and loss of beta-adrenergic stimulation. To…”
    Get full text
    Journal Article
  12. 12

    Topographic organization of Fos-like immunoreactivity in the rostral nucleus of the solitary tract evoked by gustatory stimulation with sucrose and quinine by Harrer, Marie I., Travers, Susan P.

    Published in Brain research (04-03-1996)
    “…Fos immunohistochemistry was used to elucidate the pattern of activation elicited by two qualitatively and hedonically distinct taste stimuli, sucrose and…”
    Get full text
    Journal Article
  13. 13

    Glutamate–cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress by Solis, Willy A., Dalton, Timothy P., Dieter, Matthew Z., Freshwater, Sarah, Harrer, Judy M., He, Lei, Shertzer, Howard G., Nebert, Daniel W.

    Published in Biochemical pharmacology (01-05-2002)
    “…Glutamate–cysteine ligase is a heterodimer comprising a modifier (GCLM) and a catalytic (GCLC) subunit. In mouse Hepa-1c1c7 hepatoma cell cultures, we found…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Targeted Ablation of the Phospholamban Gene Is Associated With a Marked Decrease in Sensitivity in Aortic Smooth Muscle by Lalli, Jane, Harrer, Judy M, Luo, Wusheng, Kranias, Evangelia G, Paul, Richard J

    Published in Circulation research (01-04-1997)
    “…Phospholamban (PLB) is a protein associated with the Ca+-ATPase of the sarcoplasmic reticulum (SR) in cardiac, slow-twitch skeletal, and smooth muscle. PLB…”
    Get full text
    Journal Article
  16. 16

    The Influence of Bi2O3 and Sb2O3 on the Electrical Properties of ZnO-Based Varistors by Ott, J, Lorenz, A, Harrer, M, Preissner, Ea, Hesse, C, Feltz, A, Whitehead, Ah, Schreiber, M

    Published in Journal of electroceramics (01-04-2001)
    “…This work presents a study of the influence of both Bi content and Sb/Bi ratio on the electrical characteristics of a commercial-type ZnO varistor. In contrast…”
    Get full text
    Journal Article
  17. 17

    Metyrapone and cocaine: A double-blind, placebo-controlled drug interaction study by Winhusen, T., Somoza, E., Harrer, J.M., Moore, E., Ussery, T., Kropp, F., Singal, B., Elkashef, A., Mojsiak, J.

    Published in Pharmacology, biochemistry and behavior (01-04-2005)
    “…Pre-clinical research suggests that suppression of adrenocorticosteroid synthesis might decrease susceptibility to stress-induced relapse. Metyrapone…”
    Get full text
    Journal Article
  18. 18

    Pentameric Assembly of Phospholamban Facilitates Inhibition of Cardiac Function in Vivo by Chu, G, Li, L, Sato, Y, Harrer, J M, Kadambi, V J, Hoit, B D, Bers, D M, Kranias, E G

    Published in The Journal of biological chemistry (11-12-1998)
    “…Phospholamban has been proposed to coexist as pentamers and monomers in native sarcoplasmic reticulum membranes. To determine its functional unit in vivo , we…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Monomeric Phospholamban Overexpression in Transgenic Mouse Hearts by Chu, Guoxiang, Dorn, Gerald W, Luo, Wusheng, Harrer, Judy M, Kadambi, Vivek J, Walsh, Richard A, Kranias, Evangelia G

    Published in Circulation research (01-10-1997)
    “…Phospholamban, a prominent modulator of the sarcoplasmic reticulum (SR) Ca+-ATPase activity and basal contractility in the mammalian heart, has been proposed…”
    Get full text
    Journal Article